Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZP4207 vs GlucaGen in Hypoglycemic Type 1 Diabetes Patients
NCT02660008Phase 2Completed
- Sponsor
- Zealand Pharma
- Start
- Jan 2016
- Primary completion
- Jun 2016
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of dasiglucagon in hypoglycemia, sponsored by Zealand Pharma. Started Jan 2016; status: completed.
02
Drugs
dasiglucagon
03
Conditions
hypoglycemia
Beyond the preview
Go deeper on NCT02660008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02660008.